短效脊髓麻醉对麻醉后护理病房出院的影响:回顾性分析。

The Canadian journal of hospital pharmacy Pub Date : 2025-03-12 eCollection Date: 2025-01-01 DOI:10.4212/cjhp.3618
Meghan Ludlam, Isla Drummond, Angela Lo
{"title":"短效脊髓麻醉对麻醉后护理病房出院的影响:回顾性分析。","authors":"Meghan Ludlam, Isla Drummond, Angela Lo","doi":"10.4212/cjhp.3618","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.</p><p><strong>Objective: </strong>To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.</p><p><strong>Methods: </strong>This multicentre retrospective cohort study involved adult patients who received chloroprocaine or bupivacaine as spinal anesthetic for short-duration surgery. The primary outcome was the time from admission to the postanesthesia care unit (PACU) to discharge from the PACU. Time from PACU admission to discharge readiness was also assessed, along with the perioperative variables of type of operation performed, duration of surgery, dose of anesthetic, dose of intraoperative analgesic, and number of days from operation to hospital discharge.</p><p><strong>Results: </strong>The study involved 145 patients aged 30 to 94 years: 72 who received chloroprocaine and 73 who received bupivacaine. For the primary outcome, there was a nonsignificant shorter time from PACU admission to discharge for the chloroprocaine cohort (mean difference 36 minutes, <i>p</i> = 0.07). There was a significant difference favouring chloroprocaine over bupivacaine in the time from PACU admission to meeting PACU discharge criteria (mean difference 48 minutes, <i>p</i> < 0.001). Chloroprocaine was associated with significantly shorter surgery duration (mean difference 5 minutes, <i>p</i> = 0.026). Regression analysis showed a significant correlation between the anesthetic given and the time to meeting PACU discharge eligibility (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Use of chloroprocaine was associated with earlier time to patients meeting PACU discharge criteria. These findings support the potential benefit of chloroprocaine over bupivacaine in terms of achieving earlier PACU discharge readiness, although this difference did not consistently translate into earlier actual PACU discharge.</p>","PeriodicalId":94225,"journal":{"name":"The Canadian journal of hospital pharmacy","volume":"78 1","pages":"e3618"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879361/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Short-Acting Spinal Anesthetic on Discharge from Postanesthetic Care Unit: A Retrospective Analysis.\",\"authors\":\"Meghan Ludlam, Isla Drummond, Angela Lo\",\"doi\":\"10.4212/cjhp.3618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.</p><p><strong>Objective: </strong>To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.</p><p><strong>Methods: </strong>This multicentre retrospective cohort study involved adult patients who received chloroprocaine or bupivacaine as spinal anesthetic for short-duration surgery. The primary outcome was the time from admission to the postanesthesia care unit (PACU) to discharge from the PACU. Time from PACU admission to discharge readiness was also assessed, along with the perioperative variables of type of operation performed, duration of surgery, dose of anesthetic, dose of intraoperative analgesic, and number of days from operation to hospital discharge.</p><p><strong>Results: </strong>The study involved 145 patients aged 30 to 94 years: 72 who received chloroprocaine and 73 who received bupivacaine. For the primary outcome, there was a nonsignificant shorter time from PACU admission to discharge for the chloroprocaine cohort (mean difference 36 minutes, <i>p</i> = 0.07). There was a significant difference favouring chloroprocaine over bupivacaine in the time from PACU admission to meeting PACU discharge criteria (mean difference 48 minutes, <i>p</i> < 0.001). Chloroprocaine was associated with significantly shorter surgery duration (mean difference 5 minutes, <i>p</i> = 0.026). Regression analysis showed a significant correlation between the anesthetic given and the time to meeting PACU discharge eligibility (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Use of chloroprocaine was associated with earlier time to patients meeting PACU discharge criteria. These findings support the potential benefit of chloroprocaine over bupivacaine in terms of achieving earlier PACU discharge readiness, although this difference did not consistently translate into earlier actual PACU discharge.</p>\",\"PeriodicalId\":94225,\"journal\":{\"name\":\"The Canadian journal of hospital pharmacy\",\"volume\":\"78 1\",\"pages\":\"e3618\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879361/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Canadian journal of hospital pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4212/cjhp.3618\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Canadian journal of hospital pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.3618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:氯普鲁卡因最近在加拿大作为一种短效局部麻醉剂重新获得。它提供了一种替代布比卡因的方法,布比卡因是不列颠哥伦比亚省温哥华沿海卫生站使用的主要脊髓麻醉剂。目的:比较氯普鲁卡因和布比卡因脊柱麻醉手术患者的恢复情况。方法:这项多中心回顾性队列研究纳入了接受氯普鲁卡因或布比卡因作为短时间脊柱麻醉手术的成年患者。主要观察指标为从进入麻醉后护理病房(PACU)到从PACU出院的时间。从PACU入院到准备出院的时间也被评估,以及手术类型、手术持续时间、麻醉剂量、术中镇痛剂量和手术到出院天数等围手术期变量。结果:本研究纳入145例30 ~ 94岁患者,其中72例接受氯普鲁卡因治疗,73例接受布比卡因治疗。对于主要结局,氯普鲁卡因组从PACU入院到出院的时间没有显著缩短(平均差36分钟,p = 0.07)。从PACU入院到达到PACU出院标准的时间,氯普鲁卡因优于布比卡因,差异有统计学意义(平均差异48分钟,p < 0.001)。氯普鲁卡因显著缩短手术时间(平均差5分钟,p = 0.026)。回归分析显示,麻醉剂量与满足PACU出院条件的时间有显著相关性(p < 0.001)。结论:符合PACU出院标准的患者使用氯普鲁卡因的时间越早。这些发现支持氯普鲁卡因比布比卡因在实现更早的PACU出院准备方面的潜在益处,尽管这种差异并不总是转化为更早的实际PACU出院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of Short-Acting Spinal Anesthetic on Discharge from Postanesthetic Care Unit: A Retrospective Analysis.

Background: Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.

Objective: To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.

Methods: This multicentre retrospective cohort study involved adult patients who received chloroprocaine or bupivacaine as spinal anesthetic for short-duration surgery. The primary outcome was the time from admission to the postanesthesia care unit (PACU) to discharge from the PACU. Time from PACU admission to discharge readiness was also assessed, along with the perioperative variables of type of operation performed, duration of surgery, dose of anesthetic, dose of intraoperative analgesic, and number of days from operation to hospital discharge.

Results: The study involved 145 patients aged 30 to 94 years: 72 who received chloroprocaine and 73 who received bupivacaine. For the primary outcome, there was a nonsignificant shorter time from PACU admission to discharge for the chloroprocaine cohort (mean difference 36 minutes, p = 0.07). There was a significant difference favouring chloroprocaine over bupivacaine in the time from PACU admission to meeting PACU discharge criteria (mean difference 48 minutes, p < 0.001). Chloroprocaine was associated with significantly shorter surgery duration (mean difference 5 minutes, p = 0.026). Regression analysis showed a significant correlation between the anesthetic given and the time to meeting PACU discharge eligibility (p < 0.001).

Conclusion: Use of chloroprocaine was associated with earlier time to patients meeting PACU discharge criteria. These findings support the potential benefit of chloroprocaine over bupivacaine in terms of achieving earlier PACU discharge readiness, although this difference did not consistently translate into earlier actual PACU discharge.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信